Eric Powers to Disease-Free Survival
This is a "connection" page, showing publications Eric Powers has written about Disease-Free Survival.
Connection Strength
0.012
-
Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial. Circulation. 2002 May 21; 105(20):2347-54.
Score: 0.012